Axsome Therapeutics, Inc. (FRA:19X)

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $170.99M USD in the quarter ending September 30, 2025, with 63.22% growth. This brings the company's revenue in the last twelve months to $561.26M, up 65.83% year-over-year. In the year 2024, Axsome Therapeutics had annual revenue of $385.69M with 42.53% growth.

• Revenue (ttm): $561.26M
• Revenue Growth: +65.83%
• P/S Ratio: 13.77
• Revenue / Employee: $821.76K
• Employees: 683
• Market Cap: 6.59B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	385.69M	115.09M	42.53%
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-